Signet Therapeutics is a biopharmaceutical startup focusing on developing innovative targeted cancer drugs using novel disease models.
Signet Therapeutics is a biopharmaceutical startup focusing on developing innovative targeted cancer drugs using novel disease models.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Oct 29, 2021 | Seed | $10M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Blue Ocean Capital | — | Seed |